Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Star
5960.5000 -187.50 (-3.05%)
NSE May 08, 2025 15:31 PM
Volume: 364.9K
 

5960.50
-3.05%
Karvy
Divis Labs Net revenues increased by 16.8 percent YoY to Rs 11.65 bn, which is in line with our estimates. The Operating margins were at 33 percent in Q1FY20 (much lower than our estimate of 36.0 percent) as against 35.4 percent in Q1FY19 on account of lower gross margin and higher expenditure.
Number of FII/FPI investors increased from 826 to 922 in Mar 2025 qtr.
More from Divi's Laboratories Ltd.
Recommended